Creabilis Appoints George F. Horner III as its Chairman
Mr Horner has over 40 years industry experience gained with both biotech and big pharma companies. He was most recently the CEO of Prestwick Pharmaceuticals, a private CNS company that was sold to Biovail Corporation and Ovation Pharmaceuticals in late 2008. Prior to joining Prestwick, Mr Horner was the CEO of Vicuron, a publicly listed anti-infectives company that was sold to Pfizer for $1.9 billion in 2005. Mr Horner also worked for Ligand Pharmaceuticals following a successful career at Abbott Laboratories where his final position was as President of the company’s business in Canada. Mr Horner has also acted as an adviser to a number of specialist life science investors in recent years.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.